259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index
Inflammatory breast cancer
Precancerous model of human breast epithelial cells induced by NNK for prevention
Pre-administration of docetaxel protects against adriamycin-induced cardiotoxicity
Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death
Pre-clinical validation of early molecular markers of sensitivity to aromatase inhibitors in a mouse model of post-menopausal hormone-sensitive breast cancer
Fatty acid metabolism in breast cancer cells
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
Prediction of metastatic relapse in node-positive breast cancer
Sentinel node biopsy in patients with multiple breast cancer
BRCA1/2 mutation testing in breast cancer patients
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1)
SSRI use and breast cancer risk by hormone receptor status
NSAID use and breast cancer risk in the VITAL cohort
Parity and disparity in first course treatment of invasive breast cancer
The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment
The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Identification of rare complete BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH techniques
30th Annual San Antonio Breast Cancer Symposium Late Breaking Abstracts